Cargando…

Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension

There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Cheng-Lin, Cao, Ya-Juan, Cheng, Hao, Pan, Yi-Ming, Bao, Shan-Hua, Xie, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226609/
https://www.ncbi.nlm.nih.gov/pubmed/27246983
http://dx.doi.org/10.18632/oncotarget.9641
_version_ 1782493677839450112
author Lu, Cheng-Lin
Cao, Ya-Juan
Cheng, Hao
Pan, Yi-Ming
Bao, Shan-Hua
Xie, Min
author_facet Lu, Cheng-Lin
Cao, Ya-Juan
Cheng, Hao
Pan, Yi-Ming
Bao, Shan-Hua
Xie, Min
author_sort Lu, Cheng-Lin
collection PubMed
description There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect the outcomes of selective devascularization procedures. Elucidating these features may guide future treatment of esophageal varices in patients with portal hypertension. We retrospectively analyzed medical records of 455 patients who underwent selective devascularization procedures in our center. Patients were subject to splenectomy, selective devascularization with or without esophageal transection. The mode of surgery recurred in comparable rates in both the group with major complications postoperatively (high-risk group which consisted of 63 patients) or the group without major postoperative complications (low-risk group, 392). Risk factors that negatively influenced outcomes of surgery include severe symptoms (89% in high risk group and 71% in low risk group), large volume of blood loss in the hemorrhage before surgery (81% in high risk group and 16% in low risk group), sever liver cirrhosis (83% in high risk group and 67% in low risk group), previous endotherapy, prolonged prothrombin time, and poor liver function. Selective devascularization is a feasible option to treat variceal hemorrhage in patients with portal hypertension.
format Online
Article
Text
id pubmed-5226609
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Impact Journals LLC
record_format MEDLINE/PubMed
spelling pubmed-52266092017-01-18 Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension Lu, Cheng-Lin Cao, Ya-Juan Cheng, Hao Pan, Yi-Ming Bao, Shan-Hua Xie, Min Oncotarget Clinical Research Paper There is a high incidence of death due to variceal hemorrhage in patients with portal hypertension. Factors to consider when choosing selective devascularization in the treatment of variceal hemorrhage remain a controversy. This study aims to generate the prevalent clinical risk factors that affect the outcomes of selective devascularization procedures. Elucidating these features may guide future treatment of esophageal varices in patients with portal hypertension. We retrospectively analyzed medical records of 455 patients who underwent selective devascularization procedures in our center. Patients were subject to splenectomy, selective devascularization with or without esophageal transection. The mode of surgery recurred in comparable rates in both the group with major complications postoperatively (high-risk group which consisted of 63 patients) or the group without major postoperative complications (low-risk group, 392). Risk factors that negatively influenced outcomes of surgery include severe symptoms (89% in high risk group and 71% in low risk group), large volume of blood loss in the hemorrhage before surgery (81% in high risk group and 16% in low risk group), sever liver cirrhosis (83% in high risk group and 67% in low risk group), previous endotherapy, prolonged prothrombin time, and poor liver function. Selective devascularization is a feasible option to treat variceal hemorrhage in patients with portal hypertension. Impact Journals LLC 2016-05-26 /pmc/articles/PMC5226609/ /pubmed/27246983 http://dx.doi.org/10.18632/oncotarget.9641 Text en Copyright: © 2016 Lu et al. http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Clinical Research Paper
Lu, Cheng-Lin
Cao, Ya-Juan
Cheng, Hao
Pan, Yi-Ming
Bao, Shan-Hua
Xie, Min
Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title_full Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title_fullStr Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title_full_unstemmed Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title_short Clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
title_sort clinical factors that influence the outcome of selective devascularization in the treatment of portal hypertension
topic Clinical Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5226609/
https://www.ncbi.nlm.nih.gov/pubmed/27246983
http://dx.doi.org/10.18632/oncotarget.9641
work_keys_str_mv AT luchenglin clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension
AT caoyajuan clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension
AT chenghao clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension
AT panyiming clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension
AT baoshanhua clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension
AT xiemin clinicalfactorsthatinfluencetheoutcomeofselectivedevascularizationinthetreatmentofportalhypertension